Global Biosimilars Market

The market report is designed to provide a complete view of the Global Biosimilars Market. This business intelligence report has been categorized into qualitative and quantitative insights over the forecast period (2018-2026). The report provides the following market insights which enable the enterprises and consumers to make strategic business decisions -

Strategic Market Entry - We provide detailed research support to our clients including mapping the product life cycle, key market players, consumer behaviour, and analysis of the company’s market position.

Sales Maximization - The market research report explores different avenues of maximizing sales through threat evaluation, identifying potential clients and distributors and market risks. The report provides qualitative insights into the market scenario which in turn enables the customer to evaluate business profitability.

Consumer & Competitive Scenario - As a part of consumer analysis, the report provides macro as well as micro-level insights about consumer demand, and product preferences. Companies profiled in the report include a detailed analysis of their financial performance, strategic initiatives, and SWOT analysis. Porter’s analysis provides’ market intelligence to evaluate competitive threat.

Market Estimates & Forecasts - Quantitative analysis holds a major section of the market research report. The report analyses every business segment, its market drivers and restraints, market expansion opportunities and growth rates. The report also provides a region-wise and country-wise break-up of the global market and business segments.

Vendor and Customer analysis - The report identifies the key vendors in the market along with their product portfolio, patents held by them, their market presence and extent of distribution network. This chapter enables enterprises to choose the most suitable vendor to cater to their needs and requirements.

Global Biosimilars Market, By Product:

1. Recombinant Non-Glycosylated Proteins

1.1       Human Growth Hormone

1.2       Granulocyte Colony-Stimulating Factor (Filgrastim)

1.3       Insulin

1.4       Interferon

1.4.1         Alfa

1.4.2         Beta

1. Recombinant Glycosylated Proteins

2.1       Erythropoietin

2.1.1         Alfa

2.1.2         Zeta

2.2       Monoclonal Antibodies

2.2.1         Infliximab

2.2.2         Rituximab

2.2.3         Adalimumab

2.2.4         Trastuzumab

2.2.5         Bevacizumab

2.2.6         Etanercept

2.3       Follitropin

2.3.1         Alfa

2.3.2         Beta

2.4       Low Molecular Weight Heparin (LMWHs)

Global Biosimilars Market, By Application:

1. Hematology

1.1       Neutropenia

1.2       Anemia

1.3       Others

1. Autoimmune Disease

2.1       Arthritis

2.1.1         Rheumatoid Arthritis

2.1.2         Psoriatic Arthritis

2.1.3         Juvenile Arthritis

2.1.4         Ankylosing Spondylitis

2.1.5         Others

2.2       Inflammatory Bowel Disease (IBD)

2.2.1         Ulcerative Colitis

2.2.2         Crohn's Disease

2.2.3         Others

2.3       Psoriasis

2.4       Others

1. Oncology

3.1       Lung Cancer

3.2       Brain Cancer

3.3       Breast Cancer

3.4       Cervical Cancer

3.5       Colorectal Cancer

3.6       Leukemia

3.6.1         Non-Hodgkin Lymphoma (NHL)

3.6.2         Chronic Lymphocytic Leukemia (CLL)

3.6.3         Others

3.7       Others

1. Growth Hormone Deficiency
2. Diabetes
3. Others

 Global Biosimilars Market, By Manufacturer:

1. Contract Research and Manufacturing Services
2. In-house

Global Biosimilars Market, By Techhnology:

1. Recombinant DNA Technology (rDNA technology)
2. Monoclonal Antibodies (MAb) Technology

Global Biosimilars Market, By Region:

1. North America
2. Europe
3. Asia-Pacific
4. Central & South America
5. Middle East & Africa

Global Biosimilars Market, By Country:

1. U.S.
2. Canada
3. Mexico
4. Germany
5. UK
6. France
7. Italy
8. Spain
9. Russia
10. Belgium
11. Bulgaria
12. Czech Republic
13. Denmark
14. Finland
15. Hungary
16. Greece
17. Norway
18. The Netherlands
19. China
20. India
21. Japan
22. Australia
23. Switzerland
24. Singapore
25. Malaysia
26. South Korea
27. Saudi Arabia
28. UAE
29. Brazil

Vendor Landscape: Biosimilars Market

The report contains a chapter dedicated to vendors operating in the market, covering equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

End-User Landscape (Consumer Profile): Biosimilars Market

The report provides a detailed list of end-users operating across the world. The end-user landscape includes consumer contact details, geographical presence, revenue, product portfolio, organic and inorganic growth strategies among others.

Company Profiles: Biosimilars Market

The major companies profiled in the Biosimilars Market include 3SBio, Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences, Dr. Reddy's Laboratories, Elli Lilly and Company, Intas Biopharmaceuticals, Lupin, Merck, Novartis (Sandoz), Ratiopharm, Samsung Bioepis, Sanofi, STADA Arzneimittel, Teva Pharmaceutical, Wockhardt, and Zydus Cadila among others. The Companies are investing in innovation/R&D, brand building, and fostering strong relationships with customers to enhance their competitive position.

Please note: This is not an exhaustive list of companies profiled in the report.

Check the Press Release on Global Biosimilars Market Report